C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion (Q42493935)

1 November 2017

C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion (English)

1 reference

1 November 2017

Young LH

1

1 reference

1 November 2017

Ikeda Y

series ordinal

2

1 reference

1 November 2017

Scalia R

series ordinal

3

1 reference

1 November 2017

Lefer AM

series ordinal

4

1 reference

1 November 2017

1 October 2000

1 reference

American Journal of Physiology Heart and Circulatory Physiology

1 November 2017

1 reference

1 November 2017

279

1 reference

1 November 2017

4

1 reference

1 November 2017

H1453-9

1 reference

Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus

1 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Direct measurement of nitric oxide release from vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Nitric oxide: an endogenous modulator of leukocyte adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Specific binding of proinsulin C-peptide to human cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

C-peptide revisited--new physiological effects and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

Tissue destruction by neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2000.279.4.H1453

10.1152/AJPHEART.2000.279.4.H1453

21 January 2018

Identifiers

DOI

0 references

1 reference